Sign up to save your podcasts
Or
Share Pharmacy Benefits and Disease-Modifying Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pharmacy Benefits and Disease-Modifying Therapies
Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.
View all episodes
By American Academy of Neurology
4.7
285285 ratings
Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.
More shows like Neurology® Podcast
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
497 Listeners
Practical Neurology Podcast
50 Listeners
The Curbsiders Internal Medicine Podcast
3,341 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,149 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
134 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Neurology Exam Prep Podcast
189 Listeners
The Curious Clinicians
373 Listeners
Ninja Nerd
316 Listeners
Continuum Audio
82 Listeners